Traditional first-line treatment failure rates in neuromyelitis optica spectrum disorder patients included in the Argentinean registry (RelevarEM)-Reference-Cited by-同舟云学术

Traditional first-line treatment failure rates in neuromyelitis optica spectrum disorder patients included in the Argentinean registry (RelevarEM)

Published:2024-09 Issue: Volume:89 Page:105771
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Carnero Contentti Edgar^ORCID,Lopez Pablo A,Patrucco Liliana,Cristiano Edgardo,Miguez Jimena,Silva Berenice,Liwacki Susana,Tkachuk Verónica,Balbuena María E,Vrech Carlos,Deri Norma,Correale Jorge,Marrodan Mariano,Ysrraelit María C,Fiol Marcela,Leguizamon Felisa,Luetic Geraldine,Tavolini Darío,Mainella Carolina,Zanga Gisela,Burgos Marcos,Hryb Javier,Barboza Andrés,Lazaro Luciana,Alonso Ricardo,Fernández Liguori Nora,Nadur Débora,Martinez Alejandra,Steinberg Judith,Carrá Adriana,Alonso Serena Marina,Rojas Juan I

Publisher

Elsevier BV

Reference32 articles.

1. Treating neuromyelitis optica with azathioprine: 20-year clinical practice;Bichuetti;Mult. Scler.,2019

2. Impact of rituximab in Mexican patients with Multiple Sclerosis-a single-center retrospective study;Bribiesca-Contreras;Mult. Scler. Relat. Disord.,2022

3. Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies;Carnero Contentti;J. Neuroinflammat.,2021

4. Latin American consensus recommendations for management and treatment of neuromyelitis optica spectrum disorders in clinical practice;Carnero Contentti;Mult. Scler. Relat. Disord.,2020

5. Mortality of neuromyelitis optica spectrum disorder patients in an Argentinean population: a study from the RelevarEM registry;Carnero Contentti;Mult. Scler. J. Exp. Transl. Clin.,2023